- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x GLN: GLUTAMINE(Non-covalent)
- 16 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 7 residues within 4Å:- Chain A: S.35, L.36, G.37, K.38, G.39, E.160
- Ligands: SO4.3
Ligand excluded by PLIPSO4.3: 6 residues within 4Å:- Chain A: K.38, K.60, E.160, G.162, G.163
- Ligands: SO4.2
Ligand excluded by PLIPSO4.5: 3 residues within 4Å:- Chain A: R.386, R.411, H.412
Ligand excluded by PLIPSO4.6: 3 residues within 4Å:- Chain A: K.317, F.373, R.376
Ligand excluded by PLIPSO4.12: 7 residues within 4Å:- Chain B: S.35, L.36, G.37, K.38, G.39, E.160
- Ligands: SO4.13
Ligand excluded by PLIPSO4.13: 7 residues within 4Å:- Chain B: K.38, K.60, D.62, E.160, G.162, G.163
- Ligands: SO4.12
Ligand excluded by PLIPSO4.15: 2 residues within 4Å:- Chain B: R.411, H.412
Ligand excluded by PLIPSO4.16: 2 residues within 4Å:- Chain B: K.317, R.376
Ligand excluded by PLIPSO4.20: 7 residues within 4Å:- Chain C: S.35, L.36, G.37, K.38, G.39, E.160
- Ligands: SO4.21
Ligand excluded by PLIPSO4.21: 6 residues within 4Å:- Chain C: K.38, K.60, E.160, G.162, G.163
- Ligands: SO4.20
Ligand excluded by PLIPSO4.23: 3 residues within 4Å:- Chain C: R.386, R.411, H.412
Ligand excluded by PLIPSO4.24: 3 residues within 4Å:- Chain C: K.317, F.373, R.376
Ligand excluded by PLIPSO4.30: 7 residues within 4Å:- Chain D: S.35, L.36, G.37, K.38, G.39, E.160
- Ligands: SO4.31
Ligand excluded by PLIPSO4.31: 7 residues within 4Å:- Chain D: K.38, K.60, D.62, E.160, G.162, G.163
- Ligands: SO4.30
Ligand excluded by PLIPSO4.33: 2 residues within 4Å:- Chain D: R.411, H.412
Ligand excluded by PLIPSO4.34: 2 residues within 4Å:- Chain D: K.317, R.376
Ligand excluded by PLIP- 4 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
MPD.4: 7 residues within 4Å:- Chain A: R.231, K.259, D.260, V.261, I.264, I.267
- Chain B: A.202
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:A.202, A:I.264
- Hydrogen bonds: A:V.261
MPD.14: 7 residues within 4Å:- Chain B: R.231, L.258, K.259, D.260, V.261, I.264, I.267
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:L.258, B:I.264, B:I.267
- Hydrogen bonds: B:R.231, B:V.261
MPD.22: 7 residues within 4Å:- Chain C: R.231, K.259, D.260, V.261, I.264, I.267
- Chain D: A.202
3 PLIP interactions:1 interactions with chain D, 2 interactions with chain C- Hydrophobic interactions: D:A.202, C:I.264
- Hydrogen bonds: C:V.261
MPD.32: 7 residues within 4Å:- Chain D: R.231, L.258, K.259, D.260, V.261, I.264, I.267
5 PLIP interactions:5 interactions with chain D- Hydrophobic interactions: D:L.258, D:I.264, D:I.267
- Hydrogen bonds: D:R.231, D:V.261
- 4 x MG: MAGNESIUM ION(Non-functional Binders)
MG.7: 1 residues within 4Å:- Ligands: CTP.10
No protein-ligand interaction detected (PLIP)MG.9: 1 residues within 4Å:- Ligands: CTP.8
No protein-ligand interaction detected (PLIP)MG.25: 1 residues within 4Å:- Ligands: CTP.28
No protein-ligand interaction detected (PLIP)MG.27: 1 residues within 4Å:- Ligands: CTP.26
No protein-ligand interaction detected (PLIP)- 4 x CTP: CYTIDINE-5'-TRIPHOSPHATE(Non-covalent)
CTP.8: 14 residues within 4Å:- Chain A: S.34, D.167, I.168, E.169
- Chain B: K.207, T.208, K.209, Q.212, K.243, F.247
- Chain C: Q.134, V.135, I.136
- Ligands: MG.9
36 PLIP interactions:10 interactions with chain A, 22 interactions with chain B, 4 interactions with chain C- Hydrogen bonds: A:S.34, A:S.34, A:D.167, A:I.168, A:E.169, B:T.208, B:T.208, B:T.208, B:K.209, B:K.209, B:Q.212, C:V.135, C:I.136
- Water bridges: A:S.34, A:G.166, A:D.167, A:E.169, A:E.169, B:K.207, B:K.216, B:K.216, B:K.243, B:K.243, B:K.243, B:K.243, B:K.243, C:E.175
- Hydrophobic interactions: B:F.247, C:I.136
- Salt bridges: B:K.207, B:K.207, B:K.209, B:K.209, B:K.209, B:K.243, B:K.243
CTP.10: 14 residues within 4Å:- Chain A: K.207, T.208, K.209, Q.212, K.243, F.247
- Chain B: S.34, D.167, I.168, E.169
- Chain D: Q.134, V.135, I.136
- Ligands: MG.7
29 PLIP interactions:7 interactions with chain B, 18 interactions with chain A, 4 interactions with chain D- Hydrogen bonds: B:S.34, B:S.34, B:I.168, B:E.169, A:T.208, A:K.209, A:K.209, A:Q.212, D:V.135, D:I.136
- Water bridges: B:S.34, B:E.169, B:E.169, A:K.207, A:K.207, A:K.216, A:K.216, A:K.243, A:K.243, D:E.175
- Hydrophobic interactions: A:F.247, D:I.136
- Salt bridges: A:K.207, A:K.207, A:K.209, A:K.209, A:K.209, A:K.243, A:K.243
CTP.26: 14 residues within 4Å:- Chain A: Q.134, V.135, I.136
- Chain C: S.34, D.167, I.168, E.169
- Chain D: K.207, T.208, K.209, Q.212, K.243, F.247
- Ligands: MG.27
36 PLIP interactions:10 interactions with chain C, 22 interactions with chain D, 4 interactions with chain A- Hydrogen bonds: C:S.34, C:S.34, C:D.167, C:I.168, C:E.169, D:T.208, D:T.208, D:T.208, D:K.209, D:K.209, D:Q.212, A:V.135, A:I.136
- Water bridges: C:S.34, C:G.166, C:D.167, C:E.169, C:E.169, D:K.207, D:K.216, D:K.216, D:K.243, D:K.243, D:K.243, D:K.243, D:K.243, A:E.175
- Hydrophobic interactions: D:F.247, A:I.136
- Salt bridges: D:K.207, D:K.207, D:K.209, D:K.209, D:K.209, D:K.243, D:K.243
CTP.28: 14 residues within 4Å:- Chain B: Q.134, V.135, I.136
- Chain C: K.207, T.208, K.209, Q.212, K.243, F.247
- Chain D: S.34, D.167, I.168, E.169
- Ligands: MG.25
29 PLIP interactions:18 interactions with chain C, 4 interactions with chain B, 7 interactions with chain D- Hydrophobic interactions: C:F.247, B:I.136
- Hydrogen bonds: C:T.208, C:K.209, C:K.209, C:Q.212, B:V.135, B:I.136, D:S.34, D:S.34, D:I.168, D:E.169
- Water bridges: C:K.207, C:K.207, C:K.216, C:K.216, C:K.243, C:K.243, B:E.175, D:S.34, D:E.169, D:E.169
- Salt bridges: C:K.207, C:K.207, C:K.209, C:K.209, C:K.209, C:K.243, C:K.243
- 4 x MRD: (4R)-2-METHYLPENTANE-2,4-DIOL(Non-functional Binders)
MRD.17: 2 residues within 4Å:- Chain B: I.329, K.333
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:I.329, B:K.333
MRD.18: 3 residues within 4Å:- Chain B: E.303, P.306, S.342
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.342
MRD.35: 2 residues within 4Å:- Chain D: I.329, K.333
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:I.329, D:K.333
MRD.36: 3 residues within 4Å:- Chain D: E.303, P.306, S.342
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:S.342
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lynch, E.M. et al., Human CTP synthase filament structure reveals the active enzyme conformation. Nat. Struct. Mol. Biol. (2017)
- Release Date
- 2017-04-26
- Peptides
- CTP synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x GLN: GLUTAMINE(Non-covalent)
- 16 x SO4: SULFATE ION(Non-functional Binders)
- 4 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
- 4 x MG: MAGNESIUM ION(Non-functional Binders)
- 4 x CTP: CYTIDINE-5'-TRIPHOSPHATE(Non-covalent)
- 4 x MRD: (4R)-2-METHYLPENTANE-2,4-DIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lynch, E.M. et al., Human CTP synthase filament structure reveals the active enzyme conformation. Nat. Struct. Mol. Biol. (2017)
- Release Date
- 2017-04-26
- Peptides
- CTP synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B